Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the remaining 65 percent stake for $202 million in up-front cash.

A federal investigation into the potential overuse of primary prevention implantable cardioverter defibrillators (ICDs) appears to have made hospitals more judicious in their use of the devices, according to a study published July 3 in the Journal of the American Medical Association.

Learning a heart attack patient has nonobstructive coronary arteries shouldn’t necessarily be met with relief, according to a multicenter study published in the Journal of the American Heart Association.

Health insurance does little to protect low-income families from crippling financial hardship when a relative has atherosclerotic cardiovascular disease (ASCVD), according to a study published July 3 in JAMA Cardiology.

The FDA’s rules preventing sexually active gay men from donating blood are discriminatory and based on outdated fears, a physician wrote in an op-ed piece for the Los Angeles Times.

Hybrid imaging with coronary CT angiography (CCTA) and single photon emission CT (SPECT) can provide powerful prognostic value for patients being evaluated for coronary artery disease, according to a single-center study published online July 3 in Radiology.

Two neurologists from Stanford University believe their specialty must take the lead on ensuring patients with cardiovascular implantable electronic devices (CIEDs) have access to MRI when necessary.

Human stem cells helped restore left ventricular ejection fraction (LVEF) in monkeys induced with experimental heart failure, giving scientists hope a similar treatment could work in humans following myocardial infarction.

The Face, Arm, Speech and Time (FAST)-based public education, utilized in several countries to improve stroke symptom recognition, has not improved the response to transient ischemic stroke (TIA) and minor stroke in the United Kingdom, according to new research published July 2 in JAMA Neurology.

Nearly all transcatheter heart valves (THVs) leave debris following aortic valve replacement, reinforcing the potential for embolic protection devices to reduce the burden of silent brain infarctions and future strokes.